Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Contributing Member of the Healthcare Councils

Names and details of certain GLG News authors are available only to GLG Clients and Council Members. GLG News authors are subject-matter experts within the GLG Councils and are available for expert consulting - by phone, in-person, or written analysis. To find out how to become a GLG client or Council Member, click here.

All News Analyses by this Author

Analyses are solely the work of the authors and have not been edited or endorsed by GLG.

HIV/AIDS DRUG-INDUS BIOTECH

October 27, 2009

Indus Biotech develops drug to control HIV/AIDS | www.pharmabiz.com

This is indeed great news for HIV sufferers all over the world. Since the drug is derived from botanical sources, the cost will be within the reach of millions in the developing world. It will also help those infected with HIV in the developed world where the cost of conventional therapies are extremely high.Ashok Bendre

Page : 11 to 1 of 1

Subscribe to Updates

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines

This author consults with leading institutions through GLG